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The first human virus in the genus Cardiovirus was described in 2007 and named Saffold virus (SAFV). 
Cardioviruses can cause severe infections of the myocardium and central nervous system in animals, but 
SAFV has not yet been convincingly associated with disease in humans. To study a possible association 
between SAFV and infections in the human central nervous system, we designed a real-time PCR for 
SAFV and tested cerebrospinal fluid (CSF) samples from children <4 years of age. SAFV was detected in 
2 children: in the CSF and a fecal sample from 1 child with monosymptomatic ataxia caused by 
cerebellitis and in the CSF, blood, and myocardium of another child, who died suddenly with no history of 
illness. Virus from each child was sequenced and shown to be SAFV type 2. These findings demonstrate 
that SAFV can cause serious invasive infection in children. 
Molecular biology has revolutionized the diagnostics of infectious diseases through the 
introduction of more sensitive and specific diagnostic tests. Despite these advances, the etiologic 
agents of many apparent infections are still unidentified. For example, the etiologic agent is 
unknown for many cases of apparent pneumonia (1); in a study conducted in California, USA, 
despite extensive testing and evaluation, an underlying cause of encephalitis was unidentified for 
207 (62%) of 334 patients (2). 
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During the past few years, intensive searches for new viruses, using conventional 
virologic methods and metagenomics, have resulted in the discovery of several new viruses. 
During the past decade, the family Picornavirus has grown as the number of recognized genera 
has increased from 6 to 12 (3,4); the numbers of species, types, and subtypes have increased 
even more. However, only viruses from 3 genera (Enterovirus, Hepatovirus, and Parechovirus) 
have been firmly established as being capable of causing clinically significant disease in humans. 
Viruses from other genera (Cardiovirus, Cosavirus, and Kobuvirus) have so far been detected 
only in noninvasively collected human sample material such as fecal and respiratory samples, 
and their clinical significance remains to be fully elucidated. (Invasively collected sample 
material is that from tissues considered sterile, i.e., devoid of microorganisms.) 
The phylogenetic relationships of human picornaviruses are shown in Figure 1. Most 
picornaviruses that are pathogenic to humans are ubiquitous viruses capable of causing a variety 
of diseases, from monosymptomatic febrile infection to severe infection in the central nervous 
system and myocardium. However, most of these infections are asymptomatic (5). 
Saffold virus (SAFV) was discovered by Jones et al (6) in 2007 by sequence-independent 
genomic amplification of virus isolated from a fecal sample. The sample had been obtained in 
1981 from an 8-month-old child with fever of unknown origin. The genetic sequence of the virus 
indicated that the virus belonged to the species Theilovirus of the genus Cardiovirus, which 
contains 3 other members: Theiler’s murine encephalomyelitis virus (TMEV), Vilyuisk human 
encephalomyelitis virus (VHEV), and Thera virus. In mice, TMEV is capable of causing 
infection in the central nervous system, and some variants of this virus cause a persistent 
infection and even multiple sclerosis–like disease (7). VHEV was isolated in the 1950s from 
cerebrospinal fluid (CSF) from a patient with Vilyuisk encephalomyelitis, a progressive 
neurologic disorder that occurs in indigenous populations of an isolated part of eastern Siberia 
(8). However, the correlation between VHEV and Vilyuisk encephalomyelitis is still uncertain 
because VHEV has been isolated by multiple passages in mice and thus may represent a highly 
divergent strain of TMEV. Thera virus (previously named Theiler-like rat virus) has been 
isolated from rats, but the clinical significance of infections with this virus is unknown (9,10). 
The genus Cardiovirus also contains a second species called encephalomyocarditis virus. Only 1 
serotype is known, and it is capable of causing encephalitis and myocarditis in various animals 
(11,12). 
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Since the discovery of SAFV, several articles have provided insight into its 
epidemiologic and, to a minor degree, clinical significance. Saffold viruses are distributed 
worldwide (6,13–19), and 2 serologic studies have demonstrated that infection occurs early in 
life (14,20). However, finding an association with human disease has thus far been elusive. Most 
studies (13,15,17,20–22) have tried to associate SAFV with gastroenteritis, but no convincing 
results have been produced. A few studies (16,18,21,23) analyzed the clinical significance of 
SAFV virus in the respiratory system, but no substantial association between the virus and 
respiratory symptoms or disease has been made. Only 1 study (21) reports having tested 
invasively collected sample material (CSF samples), but no findings were positive. 
To investigate the possible invasive potential of SAFV in humans, we developed a 
diagnostic PCR and tested CSF samples from a group of children. SAFV was detected in 2 of 
these children.  
Materials and Methods 
We tested previously submitted CSF samples for SAFV, reviewed the patients’ medical 
records, and sequenced the viruses isolated. The study was approved by the local ethics 
committee, De Videnskabsetiske Komiteer for Region Hovedstaden, Denmark, protocol no. H-
2–2010–019. 
CSF Specimens 
We tested 332 consecutively submitted CSF samples from 319 patients <4 years of age 
from Denmark that had been submitted to Statens Serum Institut, Copenhagen, from January 
2006 through December 2009 for viral diagnostic testing. We tested for the following viruses: 
herpes simplex virus types 1 and 2 (228 samples), varicella zoster virus (228 samples), human 
enterovirus (261 samples), and human parechovirus (88 samples since November 2008). For all 
samples, initial test results were negative.  
Fecal Samples 
We selected fecal samples from 479 children <5 years of age who had gastroenteritis that 
had been submitted for viral diagnostic testing from September 2009 through February 2010 and 
tested them for SAFV. Nucleic acid extracted from these samples was combined into 48 pools, 
with 9 or 10 samples per pool. Samples from pools with positive results were identified, and new 
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extractions from these pools were tested individually. However, enough sample material for new 
extractions was available for only about half of the samples. 
Nucleic Acid Purification 
Nucleic acids were extracted from 200 µL of CSF or blood (from SAFV-positive 
patients) by using the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany) and 
semiautomatic extraction on the QIAcube instrument (QIAGEN). Nucleic acid was extracted 
from 200-µL fecal suspension (10% in phosphate-buffered saline) by using the Total Nucleic 
Acid Isolation Kit (Roche Diagnostics GmbH, Mannheim, Germany) on the MagnaPure LC 
instrument (Roche Diagnostics GmbH). 
Nucleic Acid Amplification and Detection 
 Five microliters of extracted material was used per reverse transcription PCR (total 
volume 25 µL) by using the OneStep RT-PCR Kit (QIAGEN). The reaction mixtures contained 
1 µmol/L of each primer and 0.2 µmol/L of probe. 
Design of the primers and probe was based on an alignment of all available SAFV 
sequences in GenBank (www.ncbi.nlm.nih.gov/genbank) in July 2010 by using ClustalW 
(www.clustal.org) and Primer3 software (http://frodo.wi.mit.edu/primer3). The primers and 
probe are selective for a highly conserved part of the 5′ untranslated region (Table). The 
Strategene Mx3005P real-time thermocycler instrument (Agilent Technologies A/S, Horsholm, 
Denmark) was used for amplification and detection with the following settings: 50°C for 20 min, 
95°C for 15 min, followed by 45 cycles of 95°C for 15 sec and 55°C for 1 min. 
Genotyping by PCR and Sequencing 
Genotyping was conducted by nested PCR and sequencing of parts of the viral protein 
(VP) 1 and VP2 regions of the capsid gene by using primers listed in Table. The inner VP1 and 
VP2 primers amplified DNA fragments of 599 and 577 bp, respectively. PCR products were 
purified by using the High Pure PCR Purification kit (Roche Diagnostics GmbH) before 
sequencing, which was performed by using the inner PCR primers on an ABI automated 
sequencer and BigDye version 1.1 chemistry (both from Applied Biosystems, Darmstadt, 
Germany). Sequences were aligned, and phylogenetic analysis with known reference sequences 
was performed by using MEGA 4 software (www.megasoftware.net). The sequences have been 
submitted to GenBank under accession nos. JF693612–23. 
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Results 
SAFV was detected in CSF from 2 of the 319 children. Additional sample material from 
these 2 children was subsequently obtained and tested. From child 1, blood and CSF collected at 
the same time and a fecal sample collected 2 weeks later were tested; only the fecal sample was 
positive for SAFV. From child 2, a postmortem blood sample and a myocardial biopsy sample 
were tested; each sample was positive for SAFV. 
Child 1 
Child 1 was a 16-month-old, previously healthy boy who became ill in May 2009. The 
boy had a fever 6 days before hospital admission, followed 1 day later by sudden onset of 
monosymptomatic ataxia, with no fever. The ataxia fluctuated from causing an insecure gait to 
walking into things and falling. The patient also had intermittent difficulty controlling his arms 
when trying to eat. No history of recent travel was reported. The boy was in otherwise good 
health; he had no abnormal psychological symptoms and retained a normal degree of 
consciousness throughout the acute phase of the disease. Differential diagnoses at hospital 
admission were intracranial tumor or viral cerebellitis. The boy’s 4-year-old sister remained 
healthy. 
Laboratory test results are listed in the Appendix Table. At hospital admission, CSF 
values (leukocyte count, protein level, and glucose level) were within reference ranges, and no 
microorganisms were detected. A magnetic resonance image of the brain showed a small venous 
anomaly in the left frontal lobe but no tumor, hemorrhage, or inflammation. A fecal sample 
collected 2 weeks later was positive for parechovirus type 3 and negative for enterovirus and 
adenovirus. Parechovirus was not found in the CSF or blood. 
During the next 2 months, the ataxia remitted completely without sequelae. The diagnosis 
at this time was viral encephalitis possibly caused by parechovirus type 3. 
Child 2 
Child 2 was a 27-month-old, previously healthy girl who was found dead in her bed in 
August 2009 with no known history of disease or symptoms. During necropsy, signs of cerebral 
herniation were detected. A small vascular malformation was found in the brain, surrounded by 
edema. No signs of encephalitis or hemolytic uremic syndrome were found. 
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The following sample materials were collected: CSF, blood, feces, myocardium, 
pericardial aspirate, lung tissue, and respiratory secretions (Appendix Table). In the CSF, 
mononuclear pleocytosis was noted. Routine bacteriologic culture found coagulase-negative 
staphylococci in the CSF, a few nonhemolytic streptococci in the lung tissue, and a few 
nonhemolytic streptococci and a few Staphylococcus aureus organisms in the pericardial 
aspirate. Verotoxin-producing Escherichia coli was cultured from the fecal sample. The 
conclusion of the autopsy and laboratory findings was that cerebral herniation was the immediate 
cause of death. 
Virus from each of the 2 children was characterized by sequencing part of the VP1 region 
of the capsid gene, and the sequences were compared with those of other SAFVs detected in 
fecal samples from the patients with gastroenteritis (Figure 2). Of the 48 fecal sample pools, 10 
were positive for SAFV by PCR. From these pools, 6 individual samples were available for 
further testing; the VP2 capsid region was successfully sequenced for 4 of these 6 samples, and 
they were all SAFV type 2. Later, an SAFV type 2–specific VP1 PCR was designed, which 
provided VP1 sequences from all 6 fecal samples and samples from the 2 children reported here: 
the fecal sample from child 1 and the blood sample from child 2. The phylogenetic analysis 
(Figure 2) showed that all viruses were SAFV type 2 and that the sequences arranged in 2 
clusters with 8% nt differences and 5% aa differences between the clusters. 
Discussion 
Several novel viruses have recently been discovered by using microarrays or mass-
sequencing methods (6,21). Almost all of these viruses have been found in noninvasively 
collected patient materials, making the correlation to clinical disease difficult to establish. For 
the picornavirus group, this issue is further complicated by knowledge that this virus family can 
cause a wide variety of diseases with a high proportion of nonspecific symptoms or 
asymptomatic infections (5). 
We report 2 cases of invasive infection with SAFV type 2 in children. For each child, 
SAFV was detected in at least 1 compartment other than the central nervous system. This finding 
strengthens the evidence of an acute infection as the cause of clinical disease. In child 1, SAFV 
virus was found in the CSF and a fecal sample. In child 2, findings were even more convincing 
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because SAFV was found in 3 invasively collected samples: CSF, myocardium, and blood. No 
other credible cause of infection was found for either of the 2 children. In child 1, the only other 
positive finding was parechovirus type 3 in a fecal sample taken 2 weeks after onset of disease. 
Parechovirus was not found in the CSF and therefore seems unlikely as the cause of the acute 
symptoms. From child 2, several types of bacteria were identified, but these seem unlikely to be 
the cause of death because culture of postmortem samples often grows commensal organisms. 
The bacteria from this child were not found consistently in the tissue samples, thus making 
systemic bacterial infection less likely. Verotoxin-producing E. coli also seems an unlikely cause 
of death because no diarrhea or signs of hemolytic uremic syndrome were present before the 
child’s death or at autopsy. 
At autopsy of child 2, a small vascular malformation, surrounded by edema, was found. 
This edema could be the cause of the herniation. However, the edema might also have been 
caused by cerebral infection or septicemia. This possibility is supported by the finding of 
mononuclear cells in the spinal fluid and the direct virus identification in the CSF and blood. The 
exact cause of death and whether there is a connection between the infection and the changes 
surrounding the malformation are unclear. However, our investigations show that before her 
death, the child’s blood contained SAFV. 
Child 1 had monosymptomatic ataxia preceded by 1 day of fever. The symptoms receded 
over the next few months, and the patient recovered fully. Child 2 died without any preceding 
symptoms or any known predisposing factors; this clinical picture is sometimes found for 
patients with enteroviral infections (24). 
The finding of SAFV in invasively collected samples from the 2 children described here 
fits well with the knowledge about the picornavirus group. SAFV probably behaves similarly to 
the viruses in the enterovirus group, producing mainly asymptomatic infections but also 
producing nonspecific symptoms in other patients and severe disease in a few patients. 
Enteroviruses are known to cause many more-or-less organ-specific diseases such central 
nervous system infection (meningitis, encephalitis, and myelitis), myocarditis, enanthema, 
exanthema, and septicemia. These 2 cases fit well within the expected range of diseases 
attributed to picornaviruses, but further studies are needed to determine the exact correlation of 
SAFV to disease in humans. 
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In a previous study, Chiu et al. looked for SAFV in 400 CSF samples but found none 
(21). Lack of detection could be explained by different assay sensitivities or by the selection of 
samples tested. In their study, patient selection was based on neurologic disease and patient ages 
were not reported. 
Our study has also shown that Saffold virus type 2 circulated in Denmark in 2009, the 
same year that both children reported here became ill. Other studies have shown type 2 to be a 
common type of SAFV and to be circulating worldwide (13,15,16,18,20,21,23). Because SAFVs 
are single-stranded RNA viruses, a nucleotide variation of 8% among this restricted number of 
samples in this study is expected. 
In conclusion, we have established SAFV virus as a cause of invasive infection and a 
highly probable cause of severe disease in children. More studies are needed to further illuminate 
the role of SAFV as a human pathogen. 
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Table. Primers and probe used for diagnostic PCR and primers used to sequence Saffold virus, 2009* 
Assay, primer  Type Sequence, 5′  3′ 
Diagnostic real-time RT-PCR   
 Saffold F Forward primer CTA WCA TGC CTC CCC GAT T 
 Saffold R Reverse primer GYT TAG ACC GGG GGA ACC 
 Saffold Probe Probe TTT CTG CCC TGC TGG GCG G 
VP2 typing   
 SAFV VP2 OF Outer forward primer GAR ATG ACY AAY CTB TCW GAY AGA GT 
 SAFV VP2 OR Outer reverse primer CCR TTR AAN ACS GGY TTN AC 
 SAFV VP2 IF Inner forward primer CGG CYA YAA ACA CKC AAT C 
 SAFV VP2 IR Inner reverse primer TTD GCR TGY TGN GTC CA 
VPI typing, type 2 specific   
 SAFV-2 VP1 OF1 Outer forward primer 1 GCA GAA AAA GGA AAG GTT GC 
 SAFV-2 VP1 OF2 Outer forward primer 2 GCA GAA AAA GGC AAA GTT GC 
 SAFV-2 VP1 OR Outer reverse primer TCT TGG RCA AAA CAC TCT CA 
 SAFV-2 VP1 IF Inner forward primer CYA TAG CTC TTC CTG AAA AYC A 
 SAFV-2 VP1 IR Inner reverse primer TGR ACC GAA AAY CTG TCT GC 
*RT-PCR, reverse transcription PCR; SAFV, Saffold virus; VP, viral protein. 
 
 
 
 
 
Figure 1. Phylogenetic tree based on full-genome sequences of all known human picornavirus species, 
represented with 1 virus strain each. The tree was constructed by using the neighbor-joining method in 
MEGA4 software (www.megasoftware.net). Scale bar indicates nucleotide substitutions per site. 
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Figure 2. Phylogenetic tree showing partial viral protein (VP) 1 capsid sequences (588 nt), from the 
Saffold virus strains identified from 2 children from Denmark, 2009, and representative strains from other 
cardioviruses. The tree was constructed by using the neighbor-joining method in MEGA4 software 
(www.megasoftware.net). Scale bar indicates nucleotide substitutions per site. Highlighting indicates the 
viruses isolated from the 2 children with invasive infection, Denmark, 2009. SAFV, Saffold virus; TMEV, 
Theiler’s murine encephalomyelitis virus; TRV, thera virus; EMCV, encephalomyocarditis virus.  
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Appendix Table. Laboratory results for 2 children with Saffold virus infection, Denmark, 2009 
Analysis 
Child 1† 
 
Child 2‡ 
Spinal fluid Blood Feces Spinal fluid Blood 
Myocardial 
tissue 
Pericardial 
fluid Lung tissue 
Respiratory 
samples Feces 
Biochemistry            
 Albumin 0.09 g/L – –  – – – – – – – 
 C-reactive protein – <6 mg/L –  – – – – – – – 
 Creatinine – 41 µmol/L –  – – – – – – – 
 Glucose  3.6 mmol/L – –  – – – – – – – 
 Hemoglobin – 7.8 mmol/L –  – – – – – – – 
 IgG – 5.8 g/L –  – – – – – – – 
 Thrombocytes – 301  10
9
/L –  – – – – – – – 
 Protein 0.14 g/L – –  – – – – – – – 
 Sodium – 140 mmol/L –  – – – – – – – 
 Erythrocytes  0  10
6
/L – –  – – – – – – – 
 Leukocytes 8  10
6
/L 8.4  10
9
/L –  – – – – – – – 
Culture: bacteria Negative – –  CNS – – A few NHS A few NHS and 
Staphlylococcus 
aureus 
– VTEC 
ELISA            
 Borrelia burgdorferi – Negative IgM 
and IgG 
–  – – – – – – – 
 Endomysium antibodies – – –  – Negative – – – – – 
 Epstein Barr virus – EBNA IgG 
negative 
–  – – – – – – – 
 Haemophilus influenzae type b – – –  – 0.62 µg/mL – – – – – 
 Legionella pneumophilae – Negative IgM 
and IgG 
–  – – – – – – – 
 Mycoplasma pneumoniae – Negative IgM 
and IgG 
–  – – – – – – – 
Intrathecal synthesis            
 Borrelia burgdorferi  Negative – –  – – – – – – – 
 Herpes simplex virus Negative – –  Negative – – – – – – 
 Ig Negative – –  – – – – – – – 
 Varicella  zoster virus Negative – –  Negative – – – – – – 
PCR            
  Adenovirus Negative – Negative  – Negative Negative – – Negative – 
 Chlamydophila pneumoniae – – –  Negative – – – – – – 
 Chlamydophila psittaci  – – –  Negative – – – – – – 
 Coronavirus – – –  – – – – – Negative – 
 Enterovirus Negative – Negative  Negative Negative Negative – – – Negative 
 Epstein Barr virus Negative Negative –  – Negative – – – – – 
 Herpes simplex virus Negative Negative –  Negative – – – – – – 
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Analysis 
Child 1† 
 
Child 2‡ 
Spinal fluid Blood Feces Spinal fluid Blood 
Myocardial 
tissue 
Pericardial 
fluid Lung tissue 
Respiratory 
samples Feces 
 Influenza viruses – – –  – – – – – Negative – 
 Legionella pneumophilae – – –  Negative – – – – – – 
 Metapneumovirus – – –  – – – – – Negative – 
 Mycoplasma pneumoniae – – –  Negative – – – – – – 
 Neisseria  meningitidis – – –  Negative – – – – – – 
 Parainfluenza viruses                                                                                                                                                                                                                                                                                                                                                      – – – – – – – – Negative – 
 Parechovirus Negative – Positive  Negative Negative Negative – – – Negative 
 Parotitis virus Negative Negative –  – – – – – – – 
 Parvovirus – – –  – Negative Negative – – – – 
 Respiratory syncytial virus – – –  – – – – – Negative – 
 Rhinovirus – – –  – – – – – Negative – 
 Streptococcus pneumoniae – – –  Negative – – – – – – 
 Varicella zoster virus Negative Negative –  Negative – – – – – – 
*–, not tested or not relevant; CNS, coagulase-negative staphylococci; NHS, nonhemolytic streptococci; VTEC, verotoxin-producing Escherichia coli. 
†Previously healthy 16-month-old boy who became ill in May 2009. 
‡Previously healthy 27-month-old girl who was found dead in her bed in August 2009. 
 
